Last Updated: 31-07-2025 | Format: PDF | Report ID:20520 | Author: Lily
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $1,150 Million |
| What is the projected market size by 2035? | $2,940 Million |
| What is the market CAGR from 2025 to 2035? | 9.8% |
| Which region dominates the market? | US (74%) |
| Which product/service type dominates the market? | Assays and Kits (39%) |
| Which application leads the market? | Leukemia (34%) |
| Who are the major buyers? | Hospitals (47%), Reference Laboratories (23%) |
| What are the key market growth drivers? | Rising Incidence of Blood Cancers: The increasing prevalence of leukemia; Technological Advancements: Innovations such as automated PCR and NGS platforms are accelerating diagnostics |
| What are the major market challenges? | High Cost of Advanced Testing: Despite clinical benefits; Data Integration and Interoperability: Managing large volumes of genomic data across fragmented systems is complex |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? |
| F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen N.V., Agilent Technologies, Inc., Sysmex Corporation, Danaher Corporation, Invitae Corporation, PierianDx, Adaptive Biotechnologies, ArcherDX (A part of Invitae), Asuragen, Inc., NeoGenomics Laboratories, Inc. |
Europe Clinical Trials Services Market: by Type (Drug, Device, Procedure, Behavioral, Observational, Others), Application (Oncology, Cardiovascular, Neurology, Infectious Diseases, Immunology, Others), Distribution Channels (Hospitals, Academic & Research Institutes, CROs, Pharmaceutical Companies, Medical Device Companies, Others), Technology (eClinical Solutions, Wearable Technology, Data Management Platforms, Remote Monitoring, Cloud-based Solutions, Artificial Intelligence), Organization Size (Small, Medium, Large) and By Europe – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Vegan Beauty And Personal Care Products Market: by Type (Skincare, Haircare, Makeup, Fragrances, Bath & Shower, Others), Application (Men, Women, Children, Unisex, Elderly, Others), Distribution Channels (Supermarkets/Hypermarkets, Specialty Stores, Online Retail, Convenience Stores, Pharmacies, Others), Technology (Natural Ingredients, Synthetic-Free Formulations, Cruelty-Free Testing, Biodegradable Packaging, Plant-Based Extractions, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Biosimilars Treatment Market: by Type (Monoclonal Antibodies, Recombinant Hormones, Fusion Proteins, Immunomodulators, Insulins, Erythropoietin), Application (Oncology, Autoimmune Diseases, Chronic Diseases, Blood Disorders, Infectious Diseases, Other Applications), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Drug Stores, Others), Technology (Recombinant DNA Technology, Monoclonal Antibody Technology, Genomics, Proteomics, Bioengineering, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Digital Biomarkers Market: by Type (Wearable Devices, Mobile Health Apps, Biosensors, Clinical Trials Platforms, Digital Diagnostics, Passive Monitoring Systems), Application (Cardiovascular Disease, Neurodegenerative Disorders, Diabetes, Respiratory Disease, Oncology, Others), Distribution Channels (Hospitals, Clinics, Research Centers, Homecare, Pharmacies, Online), Technology (Artificial Intelligence, Internet of Things, Machine Learning, Cloud Computing, Blockchain, Data Analytics), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025